Adults with gender identity disorder (GID)—commonly termed transsexualism—may seek psychiatric assessment and treatment for a variety of reasons. Some—but not all—might be candidates for hormone replacement therapies or sex reassignment surgery (SRS). For those with gender dysphoria, psychological assessment and psychotherapy are suggested and sometimes required.
Your role in the GID patient’s gender exploration and transition must be tailored to his or her gender identity and individual circumstances. For patients who are not candidates for surgery or cannot afford it, you may assist in exploring options for living with one’s gender identity.
WHAT IS GID?
Gender identity disorder is a rare, complex condition in which individuals of unambiguous genotype and phenotype identify with the opposite gender. One in 54,000 individuals are estimated to have GID:
- 75% are biologic males desiring reassignment to female gender (MTF)
- 25% are females desiring to be male (FTM).1
Table 1
DSM-IV-TR criteria for gender identity disorder
Criterion A | A strong and persistent cross-gender identification defined as the desire to be or the insistence that one is of the other sex (must not be merely a desire for any perceived cultural advantages of being the other sex) |
Criterion B | Persistent discomfort with one’s assigned sex or a sense of inappropriateness in the gender role of that sex |
Criterion C | The disturbance is not concurrent with a physical intersex condition (such as partial androgen insensitivity syndrome or congenital adrenal hyperplasia) |
Criterion D | The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning |
Source: Reference 2 |
ICD-10 diagnoses for gender identity disorder in adults
Diagnosis | Criteria |
---|---|
Transsexualism |
|
Dual-role transvestism |
|
Other gender identity disorders | No specific criteria; could be used for persons with an intersexed condition |
Gender identify disorder, unspecified | No specific criteria; could be used for persons with an intersexed condition |
Source: Adapted from International Classification of Diseases, 10th ed. (ICD-10) |
Epidemiologic studies of GID are rare, but in a survey by Rachlin et al4 of 23 MTFs and 70 FTMs:
- most underwent hormone therapy (64% of MTFs, 80% of FTMs) and/or name change (45% of MTFs, 72% of FTMs)
- none of the MTFs had breast augmentation, whereas 52% of FTMs had undergone mastectomy and reconstruction and another 33% were actively planning it
- 3% of FTMs had genital surgery, 16% were planning it, and 29% had decided definitely not to have it
- 9% of MTFs decided definitely not to have genital surgery; 23% had undergone genital surgery, and another 35% were actively planning it.
Biologic basis. GID’s cause remains unknown. Organic differences in brain anatomy have been identified in patients with GID. Zhou et al6 showed that the volume of the central subdivision of the bed nucleus of the stria terminalis (BSTc)—a brain area essential for sexual behavior—is larger in men than in women. A female-sized BSTc was found in MTF GID patients.
Research, mainly on biologic boys, indicates that GIDs are usually associated with behavioral difficulties, relationship problems with peers and parents, and—most notably—separation anxiety disorder.7 An audit of the files of 124 children and adolescents with GID showed that 42% experienced loss of one or both parents, mainly through separation.8
Psychiatric comorbidity. Studies using standardized diagnostic instruments to assess psychiatric comorbidity in GID are rare. A study of 31 patients with GID found that many met diagnostic criteria for lifetime psychiatric comorbidity, including: